INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

26,614 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$455K
1,013 sh
Nov 13, 2025
Page 649 of 666
← PrevNext →
Nov 14, 2025
traded Nov 13, 2025
+1d
SEC Form 4

Evidence

4
HX
Hao XinyanChief Operating Officer
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$281K
8,568 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

4
HX
Hao XinyanChief Operating Officer
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$768K
24.6K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

4
HX
Hao XinyanChief Operating Officer
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$683K
21.4K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

4
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$724K
1,599 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

1
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$119K
261 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

1
HX
Hao XinyanChief Operating Officer
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$176K
5,446 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

1
GY
Greenstreet YvonneDirector, Chief Executive Officer
ALNYALNYLAM PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$89K
195 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

57
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.53M
32.7K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

54
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$424K
10.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$17.44M
26.8K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
KD
Karydas DaphneDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$463K
10.1K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$11.38M
17.5K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$20.10M
30.9K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$12.58M
19.2K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$13.50M
20.7K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

53
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.79M
38.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.55M
2,399 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.76M
2,684 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$6.14M
9,392 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$2.81M
4,367 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.42M
2,194 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.43M
2,201 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$6.24M
9,619 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$235K
5,000 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

51
KD
Karydas DaphneDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$226K
4,885 sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

50
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$593K
12.7K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

50
GP
Gu PaulDirector, Chief Technology Offier
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$3.14M
80.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

49
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$5.15M
112.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

48
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$988K
1,535 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

48
DS
Dewan SameerSenior Vice President
GGenpact LTD
Open-market sale
SELL$1.19M
26.5K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

48
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$315K
480 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

47
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$91K
1,933 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

47
GP
Gu PaulDirector, Chief Technology Offier
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$784K
20.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

47
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$233K
5,000 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$473K
11.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$382K
8,456 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$359K
8,485 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$539K
13.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

45
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.54M
32.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence